Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Wasp

Product Description

WASP 150 pixels JPEG1.jpgThe KBiosystems Wasp Thermal Microplate & Microtube Sealer continues to impress with its speed, ease of use, versatility, reliability and small footprint, accommodating deep well, assay, PCR and compound storage microplates. The Wasp is perfect for robotic integration with full operation and interrogation with RS232 and has an extended shuttle option for greater plate access. Suitable for all seal types including gas permeable, the KBiosystems Wasp is the perfect choice for standalone or integrated Thermal Microplate Sealing. With the touch screen commands, the Wasp is an easy to use instrument within the lab environment.

Key Features:

Operator Friendly – Touch Screen allows fast and easy manual operation as a standalone product

Adaptable – The Wasp will automatically adjust allowing the instrument to be used with a wide range of microplates and tube racks with plate stage inserts to allow use of more unusual microplate types

Fast – With fast sealing times and no cooling required allows multiple plates to be sealed per run.

Versatile – Able to use all seal types and leading the market in Gas Permeable applied seals.

Reliable – Engineered with robustness in mind

Perfect for Integration – The small footprint of the Wasp and a large number of successful
integrations have made the Wasp the ideal choice for systems integrators.
Product Wasp
Company KBiosystems
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

KBiosystems
Units 5 to 10 Paycocke Close Basildon Essex

Tel: +44 (0) 1268 522431
Fax: +44 (0) 1268 270231
Email: sales@kbiosystems.com



Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!